[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628000":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":10,"responsibleParty":26,"collaborators":10,"id":28,"slug":29,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":32,"acronym":33,"eligibilityCriteria":34,"healthyVolunteers":30,"sex":35,"minAge":36,"maxAge":10,"enrollmentInfo":37,"targetDuration":10,"studyType":40,"phases":10,"briefSummary":41,"conditions":42,"keywords":10,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":10},{"fullName":5,"class":6},"Centre Hospitalier Intercommunal Creteil","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients diagnosed with squamous cell carcinoma of the anal canal",null,"Adult patients diagnosed with histologically confirmed anal squamous cell carcinoma.",[13],"Other: self-administered questionnaire",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"self-administered questionnaire","Completion of a self-administered questionnaire by the patient to collect information about their care journey, any difficulties or hesitations, as well as their knowledge of the link between papillomavirus and cancer.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":24,"email":25},"ISABELLE ETIENNEY","CONTACT","(0)1 44 64 20 16 51","+33","ietienney@hopital-dcss.org",{"type":27,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100628000","towards-an-understanding-of-barriers-and-delays-in-the-diagnosis-of-anal-cancer-100628000",false,"NCT07455942","Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer","FRACAS","Inclusion Criteria:\n\n1. Male or female ≥ 18 years\n2. Histologically proven invasive or microinvasive squamous cell carcinoma of the anus\n3. Having read and understood the information letter provided, either:\n\n   i. After disclosure of the diagnosis, or ii. At the latest 6 months after initiation of treatment (surgical excision, radiotherapy, or chemoradiotherapy)\n4. Affiliated with a social security system\n\nExclusion Criteria:\n\n1. Refusal to participate in the protocol\n2. Other histological types: lymphoma, adenocarcinoma, neuroendocrine tumor, etc.\n3. Time since treatment initiation greater than 6 months\n4. Protected persons (pregnant women, breastfeeding women, individuals under guardianship or curators, minors, persons deprived of liberty, or persons unable to express informed consent).","ALL","18 Years",{"count":38,"type":39},300,"ESTIMATED","OBSERVATIONAL","This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.",[43,44],"Squamous Cell Carcinoma of the Anal Canal","HPV-induced Cancer","NOT_YET_RECRUITING","2026-06-11",{"date":48,"type":49},"2026-06-12","ACTUAL",{"date":51,"type":39},"2026-06-30",{"date":53,"type":39},"2028-12-31",{"name":5,"class":6}]